Page 5 of pharmaceutical

Aurigene Oncology reports positive outcomes of Phase 1 trial for CAR-T cell therapy in India

Q3FY25 Results: Dr. Reddy’s Laboratories reports over 2 percent rise in profit YoY; Revenue at Rs 8358.6 crore

In the Global Generics Business, the company reported Q3FY25 revenues at Rs.7380 crore, YoY growth of 17% and QoQ growth…

January 23, 2025 17:17 IST

Piramal Pharma, Piramal Pharma Q2 results, quarter results, profit, revenue, pharma sector, EBITDA, CDMO business, Consumer Healthcare

Sweet pill! Pharma sector expects 10% revenue growth in FY25 says CRISIL

The pharma sector is expected to see a growth of 10 per cent in FY 25. The overall operational margins…

September 23, 2024 14:19 IST

pharmaceuticals industry, pharma companies, domestic business, price hike, volume growth, value growth, cardiac segment, gastro-intestinal, anti-infectives, gynecology, oncology

Bitter pill for pharma: Growth worries plague most companies in August, green shoots expected in FY25

Elara Capital said that organic growth will be in the range of 11-14 per cent for pharma stocks but will…

September 11, 2024 12:05 IST

Pharmaceuticals sector, China+1, CDMO companies, exports, drug development, commercial manufacturing, generics pharmaceutical drugs, funding

Acceleration in China+1 trend in Pharmaceuticals sector!

Improving the funding environment for global biotech means greater potential volumes for Indian CDMO companies. This highlights the potential of…

August 31, 2024 13:29 IST

Glenmark Pharma, US investigations, US Department of Justice, settlement

Glenmark Pharma records surge in Q1 profit at Rs 340.27 crore on strong demand, CMD says confident of meeting FY25 objectives

Glenmark Pharmaceuticals recorded revenue from operations at Rs 3244.19 crore, up 6.9 per cent as against Rs 3036.07 crore during…

August 15, 2024 12:15 IST

Nichepharm acquires 24% remaining shares from Recipharm AB to restore 100% ownership

Recipharm had taken an 8% stake in Nichepharm for approximately Rs 85 crore in 2019, with the option to pick…

July 31, 2024 21:21 IST

Mankind Pharma, Mankind Pharma Q1 results, quarter earnings, profit, revenue, exports, domestic business, Pharmaceutical industry

Mankind Pharma Q1 Results: Profit rises by 10.2% to Rs 536.49 crore, revenue at Rs 2,893.42 crore

Mankind Pharma recorded revenue from operations at Rs 2,893.42 crore, up 12.2 per cent as against Rs 2,578.62 crore during…

July 31, 2024 15:58 IST

Ajanta Pharma Q1 Results: Profit rises by 18.1% to Rs 245.77 crore, revenue up 12.1% on-year

Ajanta Pharma posted revenue from operations at Rs 1144.92 crore, up 12.1 per cent as against Rs 1021.04 crore during…

July 30, 2024 16:17 IST

oldest billionaires, richest old billionaires, who is kushal pal singh, indian billionaires list, top billionaires oldest indian

Kushal Pal Singh with $18.9 billion to Kishore Mariwala with $3.0 billion: The oldest billionaires in India

These nonagenarian billionaires have not only built and sustained successful businesses but have also contributed significantly to India’s economic growth…

June 12, 2024 00:11 IST

Alembic Pharmaceuticals gets USFDA nod to its generic formulation to treat heart failure

Can India’s life sciences industry transform from ‘pharmacy of the world’ to ‘innovation hub’?

As a global nerve center, for the manufacturing and distribution of affordable life-saving medications—the “pharmacy of the world’—India supplies generic…

June 2, 2024 14:43 IST

USFDA gives tentative approval to Lupin’s drug for treatment of rare genetic disorder

Migalastat Capsules (RLD Galafold) had estimated annual sales of USD 388 million in the U.S. (IQVIA MAT December 2023).

April 1, 2024 16:12 IST

pharmaceutical companies, pharmaceutical industry, revenue growth, domestic market, emerging market, liquidity position, new product launches, complex generics, US market, Europe market, USFDA, pharma manufacturing

Indian pharma companies to post revenue growth of 8-10% in FY2025; US & Europe growth momentum to moderate, says ICRA

Mythri Macherla, Assistant Vice President & Sector Head, ICRA, said “The operating profit margin (OPM) for the sample set companies…

March 28, 2024 16:11 IST

Suven Pharmaceuticals to merge with Cohance Lifesciences for integrated Pharma CDMO Leadership in India

According to the press statement, this deal strengthens Suven’s CDMO industry leadership position with niche capability and scale benefits.

March 1, 2024 09:23 IST

Zydus gets WHO prequalification for its key formulation to treat Kala Azar

According to WHO, there are three main forms of the disease: cutaneous leishmaniasis (CL), visceral leishmaniasis (VL), also known as…

February 25, 2024 13:40 IST

AstraZeneca, AstraZeneca India, cancer, breast cancer, healthcare news, pharma news,

AstraZeneca’s DKD pipeline highlights potential to differentiate in kidney disease space

AstraZeneca progressed tozorakimab into Phase IIb for DKD in 2019, as there was evidence that increased inflammation is associated with…

February 20, 2024 07:03 IST

Natco Pharma, Natco Pharma Q3 results, quarter earnings, profit, revenue, EBITDA, interim dividend

Natco Pharma Q3 profit jumps 241.4% to Rs 212.70 crore, interim dividend announced

Natco Pharma posted revenue from operations at Rs 758.60 crore, up 54 per cent in comparison to Rs 492.50 crore…

February 14, 2024 15:08 IST

We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences

We have been investing in our own R&D initiative which has been gathering momentum over the last few quarters, Vaidyanathan…

February 13, 2024 16:05 IST

USFDA gives nod to Lupin's generic formulation for heart rhythm disorder treatment

USFDA gives nod to Lupin’s generic formulation to treat ocular pain

Bromfenac Ophthalmic Solution 0.075 percent (RLD BromSite) had estimated annual sales of USD 15 million in the U.S. (IQVIA MAT…

February 7, 2024 12:13 IST

Related News

From H-1B to green card: Follow the journey of an Indian entrepreneur to $3.7 billion

Indian techie overcomes H-1B challenges, gets green card, quits job, and achieves $3.7 billion success

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

EB-5 fees, EB-5 filing fees cut, EB-5 visa, USCIS EB-5 rule, DHS EB-5 rule, Form I-526 fee reduction, Form I-829 petition, EB-5 investor program, EB-5 technology fee, EB-5 program changes

US cuts EB-5 fees for foreign investors seeking employment-based green cards

Jefferies buy recommendations, Jefferies stock picks India

3 ‘Buy’ recommendations by Jefferies, with up to 34% upside potential

gold price, silver price, gold market, silver market, gold price today, silver price today, silver investment, buy gold, buy silver, gold price fall, silver price fall, gold price prediction, silver price prediction,

Gold, Silver Crash Sparks Investor Debate: Technical correction or end of the rally?

UP Minister Baby escapes collision on Agra-Lucknow Expressway as truck tyre bursts

India News30 min ago

Uttar Pradesh’s Minister for Women Welfare and Child Development, Baby Rani Maurya, narrowly escaped a road accident on the Agra-Lucknow Expressway. Her driver’s quick reflexes prevented a major accident after their car collided with a truck. Maurya has instructed authorities to review safety measures on the expressway. In a separate incident, three people were killed.

View all shorts